[(1R,6R,15S,16S,18R,19S,20R,21R,22R,23S,24R)-3,16,18,20,21,22,23,24-octahydroxy-19-[(E,3S)-3-hydroxyoct-1-enyl]-3,8,13-trioxo-2,4,7-trioxa-3λ5-phosphabicyclo[13.6.3]tetracosan-6-yl]methyl (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

C51H85O17P — CID 156981278

IUPAC[(1R,6R,15S,16S,18R,19S,20R,21R,22R,23S,24R)-3,16,18,20,21,22,23,24-octahydroxy-19-[(E,3S)-3-hydroxyoct-1-enyl]-3,8,13-trioxo-2,4,7-trioxa-3λ5-phosphabicyclo[13.6.3]tetracosan-6-yl]methyl (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCCCCC(=O)OC[C@@H]1COP(=O)(O)O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CC(=O)CCCCC(=O)O1)[C@@H](O)C[C@@H](O)[C@H](/C=C/[C@@H](O)CCCCC)[C@@H](O)[C@H]2O
InChIInChI=1S/C51H85O17P/c1-3-5-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-24-29-44(56)65-35-39-36-66-69(63,64)68-51-49(61)46(58)40(32-31-37(52)27-23-6-4-2)42(54)34-43(55)41(47(59)48(60)50(51)62)33-38(53)28-25-26-30-45(57)67-39/h5,7,9-10,12-13,15-16,31-32,37,39-43,46-52,54-55,58-62H,3-4,6,8,11,14,17-30,33-36H2,1-2H3,(H,63,64)/b7-5-,10-9-,13-12-,16-15-,32-31+/t37-,39+,40-,41-,42+,43-,46+,47+,48-,49+,50+,51+/m0/s1
InChIKeySZOHGVZWYSBNJM-BKZFKKFMSA-N
MW1001.20 g/mol
LogP6.06
Rot. Bonds24

About [(1R,6R,15S,16S,18R,19S,20R,21R,22R,23S,24R)-3,16,18,20,21,22,23,24-octahydroxy-19-[(E,3S)-3-hydroxyoct-1-enyl]-3,8,13-trioxo-2,4,7-trioxa-3λ5-phosphabicyclo[13.6.3]tetracosan-6-yl]methyl (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

[(1R,6R,15S,16S,18R,19S,20R,21R,22R,23S,24R)-3,16,18,20,21,22,23,24-octahydroxy-19-[(E,3S)-3-hydroxyoct-1-enyl]-3,8,13-trioxo-2,4,7-trioxa-3λ5-phosphabicyclo[13.6.3]tetracosan-6-yl]methyl (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate (PubChem CID 156981278) has the molecular formula C51H85O17P and a molecular weight of 1001.20 g/mol. Its IUPAC name is [(1R,6R,15S,16S,18R,19S,20R,21R,22R,23S,24R)-3,16,18,20,21,22,23,24-octahydroxy-19-[(E,3S)-3-hydroxyoct-1-enyl]-3,8,13-trioxo-2,4,7-trioxa-3λ5-phosphabicyclo[13.6.3]tetracosan-6-yl]methyl (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate.

Molecular Properties

Compound Name[(1R,6R,15S,16S,18R,19S,20R,21R,22R,23S,24R)-3,16,18,20,21,22,23,24-octahydroxy-19-[(E,3S)-3-hydroxyoct-1-enyl]-3,8,13-trioxo-2,4,7-trioxa-3λ5-phosphabicyclo[13.6.3]tetracosan-6-yl]methyl (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate
PubChem CID156981278
Molecular FormulaC51H85O17P
Molecular Weight1001.20 g/mol
Exact Mass1000.55
IUPAC Name[(1R,6R,15S,16S,18R,19S,20R,21R,22R,23S,24R)-3,16,18,20,21,22,23,24-octahydroxy-19-[(E,3S)-3-hydroxyoct-1-enyl]-3,8,13-trioxo-2,4,7-trioxa-3λ5-phosphabicyclo[13.6.3]tetracosan-6-yl]methyl (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCCCCC(=O)OC[C@@H]1COP(=O)(O)O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CC(=O)CCCCC(=O)O1)[C@@H](O)C[C@@H](O)[C@H](/C=C/[C@@H](O)CCCCC)[C@@H](O)[C@H]2O
InChIInChI=1S/C51H85O17P/c1-3-5-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-24-29-44(56)65-35-39-36-66-69(63,64)68-51-49(61)46(58)40(32-31-37(52)27-23-6-4-2)42(54)34-43(55)41(47(59)48(60)50(51)62)33-38(53)28-25-26-30-45(57)67-39/h5,7,9-10,12-13,15-16,31-32,37,39-43,46-52,54-55,58-62H,3-4,6,8,11,14,17-30,33-36H2,1-2H3,(H,63,64)/b7-5-,10-9-,13-12-,16-15-,32-31+/t37-,39+,40-,41-,42+,43-,46+,47+,48-,49+,50+,51+/m0/s1
InChIKeySZOHGVZWYSBNJM-BKZFKKFMSA-N
XLogP6.06
TPSA287.27 Ų
H-Bond Donors9
H-Bond Acceptors16
Rotatable Bonds24
Heavy Atoms69
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001001.20
LogP ≤ 56.06
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze [(1R,6R,15S,16S,18R,19S,20R,21R,22R,23S,24R)-3,16,18,20,21,22,23,24-octahydroxy-19-[(E,3S)-3-hydroxyoct-1-enyl]-3,8,13-trioxo-2,4,7-trioxa-3λ5-phosphabicyclo[13.6.3]tetracosan-6-yl]methyl (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(1R,6R,15S,16S,18R,19S,20R,21R,22R,23S,24R)-3,16,18,20,21,22,23,24-octahydroxy-19-[(E,3S)-3-hydroxyoct-1-enyl]-3,8,13-trioxo-2,4,7-trioxa-3λ5-phosphabicyclo[13.6.3]tetracosan-6-yl]methyl (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate?
The IUPAC name of [(1R,6R,15S,16S,18R,19S,20R,21R,22R,23S,24R)-3,16,18,20,21,22,23,24-octahydroxy-19-[(E,3S)-3-hydroxyoct-1-enyl]-3,8,13-trioxo-2,4,7-trioxa-3λ5-phosphabicyclo[13.6.3]tetracosan-6-yl]methyl (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate (CID 156981278) is [(1R,6R,15S,16S,18R,19S,20R,21R,22R,23S,24R)-3,16,18,20,21,22,23,24-octahydroxy-19-[(E,3S)-3-hydroxyoct-1-enyl]-3,8,13-trioxo-2,4,7-trioxa-3λ5-phosphabicyclo[13.6.3]tetracosan-6-yl]methyl (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate.
What is the SMILES notation for [(1R,6R,15S,16S,18R,19S,20R,21R,22R,23S,24R)-3,16,18,20,21,22,23,24-octahydroxy-19-[(E,3S)-3-hydroxyoct-1-enyl]-3,8,13-trioxo-2,4,7-trioxa-3λ5-phosphabicyclo[13.6.3]tetracosan-6-yl]methyl (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate?
The canonical SMILES for [(1R,6R,15S,16S,18R,19S,20R,21R,22R,23S,24R)-3,16,18,20,21,22,23,24-octahydroxy-19-[(E,3S)-3-hydroxyoct-1-enyl]-3,8,13-trioxo-2,4,7-trioxa-3λ5-phosphabicyclo[13.6.3]tetracosan-6-yl]methyl (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate is CC/C=C\C/C=C\C/C=C\C/C=C\CCCCCCCCC(=O)OC[C@@H]1COP(=O)(O)O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CC(=O)CCCCC(=O)O1)[C@@H](O)C[C@@H](O)[C@H](/C=C/[C@@H](O)CCCCC)[C@@H](O)[C@H]2O.
What is the InChIKey of [(1R,6R,15S,16S,18R,19S,20R,21R,22R,23S,24R)-3,16,18,20,21,22,23,24-octahydroxy-19-[(E,3S)-3-hydroxyoct-1-enyl]-3,8,13-trioxo-2,4,7-trioxa-3λ5-phosphabicyclo[13.6.3]tetracosan-6-yl]methyl (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate?
The InChIKey is SZOHGVZWYSBNJM-BKZFKKFMSA-N. The full InChI is InChI=1S/C51H85O17P/c1-3-5-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-24-29-44(56)65-35-39-36-66-69(63,64)68-51-49(61)46(58)40(32-31-37(52)27-23-6-4-2)42(54)34-43(55)41(47(59)48(60)50(51)62)33-38(53)28-25-26-30-45(57)67-39/h5,7,9-10,12-13,15-16,31-32,37,39-43,46-52,54-55,58-62H,3-4,6,8,11,14,17-30,33-36H2,1-2H3,(H,63,64)/b7-5-,10-9-,13-12-,16-15-,32-31+/t37-,39+,40-,41-,42+,43-,46+,47+,48-,49+,50+,51+/m0/s1.
What are the key properties of [(1R,6R,15S,16S,18R,19S,20R,21R,22R,23S,24R)-3,16,18,20,21,22,23,24-octahydroxy-19-[(E,3S)-3-hydroxyoct-1-enyl]-3,8,13-trioxo-2,4,7-trioxa-3λ5-phosphabicyclo[13.6.3]tetracosan-6-yl]methyl (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate?
[(1R,6R,15S,16S,18R,19S,20R,21R,22R,23S,24R)-3,16,18,20,21,22,23,24-octahydroxy-19-[(E,3S)-3-hydroxyoct-1-enyl]-3,8,13-trioxo-2,4,7-trioxa-3λ5-phosphabicyclo[13.6.3]tetracosan-6-yl]methyl (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate has a molecular weight of 1001.20 g/mol, XLogP of 6.06, 24 rotatable bonds, 9 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for [(1R,6R,15S,16S,18R,19S,20R,21R,22R,23S,24R)-3,16,18,20,21,22,23,24-octahydroxy-19-[(E,3S)-3-hydroxyoct-1-enyl]-3,8,13-trioxo-2,4,7-trioxa-3λ5-phosphabicyclo[13.6.3]tetracosan-6-yl]methyl (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate is sourced from PubChem (CID 156981278), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).